Apotex Inc v. Novartis AG

Teresa S. Rea

Novartis MS patent on 0.5 mg fingolimod dose faces 3 challenges: prior art cited for obviousness & anticipation of all 6 claims without loading dose.

Judge	Cases	Inst. Rate	FWD Inv. Rate
Christopher M Kaiser	400+	56%	69%
Kristi Lr Sawert	300+	57%	85%
Lora M Green	400+	53%	71%

Name	Ratings
Apotex Inc	L5A
Apotex Corp	L5A
Teva Pharmaceuticals USA Inc	L3A
Argentum Pharmaceuticals LLC	L2A
Sun Pharmaceutical Industries Ltd	L2B
Sun Pharmaceutical Industries Inc	L2B
Sun Pharma Global FZE	L2B
Actavis Elizabeth LLC	L2C

Name	Ratings
Wilson Sonsini Goodrich & Rosati	L5A
Steven W. Parmelee	L3A
Michael Rosato	L3A
Jad A. Mills	L2C
Kirkland & Ellis LLP	L5A
Amanda J. Hollis	L3A
Eugene Goryunov	L3A
Winston & Strawn LLP	L5B
Samuel S. Park	L3A
Crowell & Moring LLP	L5E
Deborah Yellin	L3E
Teresa S. Rea	L2B
Shannon Lentz	L2C
Argentum Pharmaceuticals	L1C
Tyler C. Liu	L1C

Name	Ratings
Gibson Dunn & Crutcher LLP	L4D
Jane M. Love	L3E